WuXi Biologics
Offering End-to-End Solutions
Company
Vision
& Mission
“Every drug can be made and every disease can be treated” by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry
To accelerate and transform the discovery, development and manufacturing of biologics through a comprehensive open-access platform, enabling our global healthcare partners and benefiting patients worldwide
WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company’s history and achievements demonstrate its commitment to providing a truly ONE-stop service offering and strong value proposition to its global clients. The company is currently conducting on behalf of its clients and partners (as of June 30, 2021) a total of 408 integrated projects, including 212 in pre-clinical development stage; 160 in early-phase (phase I and II) clinical development; 32 in late-phase (phase III) development; and 4 in commercial manufacturing. With a total estimated capacity of exceeding 430,000 liters for biopharmaceutical production planned after 2024 in China, Ireland, the U.S., Germany, and Singapore, WuXi Biologics will provide its biomanufacturing partners with a robust and premier-quality global supply chain network.
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of its ethos and business strategy and aims to become a global ESG leader in biologics manufacturing. We use next-generation clean biomanufacturing technologies and utilize cleaner energy sources. We have also established an ESG committee led by the CEO to increase efficiency while advancing commitment to sustainability.
projects in pre-clinical development stage
projects in early-phase clinical trials
projects in late-phase clinical trials
projects in commercial manufacturing
Culture
Integrity, Dedication, Working Together & Sharing Success
-
Put Customers First
Exceed customers’ expectations, maximize the value for our customers, and win customers’ loyalty with a 100% customer retention rate.
-
Demonstrate Integrity
Take the initiative to promote a positive work environment where doing the right thing is the standard. Be positive and enthusiastic, approach challenges with energy and optimism.
-
Strive for Excellence
Pursue focus and expertise, and optimize processes in order to deliver excellent results. Relentlessly drive learning, accumulation, improvement and innovation.
-
Execute for Results
Drive effective execution of each project and objective, focusing on solutions and results.
-
Pursue Collaboration and Teamwork
Engage in collaboration and mutual development with an open and win-win mindset by sharing resources and leveraging the complementary advantages of each.
-
Embrace Change and Drive Innovation
Demonstrate flexibility and ability to embrace change. Adapt quickly to transformational and innovative conditions with a strong commitment to breakthroughs and development.
History & Awards
Business Ethics & IP Policy
As a leading global open-access biologics technology platform, WuXi Biologics is committed to the highest possible standards of openness, probity and accountability. Employees, officers and directors strive to deal honestly, ethically and fairly with our suppliers, customers, competitors and employees. Statements regarding the Company’s products and services must not be false, misleading, deceptive or fraudulent. Accordingly, WuXi Biologics strives to conduct business with individuals and organizations who share our commitment to high ethical standards and who operate in a socially and environmentally responsible manner.
In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel. Compliance reporting: IA_biologics@wuxibiologics.com
《Anti-Corruption Policy of WuXi Biologics》 《WHISTLEBLOWING AND INVESTIGATION》 《THE CONFLICT OF INTEREST POLICY》
《CODE OF BUSINESS CONDUCT AND ETHICS》 《CODE OF BUSINESS CONDUCT AND ETHICS of WuXi Biologics Business Partner》
“Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.”
Intellectual Property Protection is the foundation of trust between WuXi Biologics and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for prosecution of IP violations. We guard IP with founding principles of integrity, world-class security, zero-tolerance policy enforcement, and relentless pursuit of justice against any criminal act.
Environmental, Social and Governance
Pioneer and Promote Green Practices
Give Back to Community
the Wild Animal Friendly undertaking as a pharmaceutical enterprise
Improve Corporate Governance
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?